Cypress Capital, LLC Genprex, Inc. Call Options Transaction History

Cypress Capital, LLC

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $43.2M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital, LLC with notifications on news.